Rosetta Genomics Ltd. (NASDAQ:ROSG) shares saw an uptick in trading volume on Monday . 874,242 shares traded hands during trading, an increase of 288% from the previous session’s volume of 225,529 shares.The stock last traded at $0.59 and had previously closed at $0.58.
Separately, Barrington Research downgraded shares of Rosetta Genomics from an “outperform” rating to a “market perform” rating in a research report on Monday, December 18th.
The company has a quick ratio of 2.10, a current ratio of 2.10 and a debt-to-equity ratio of 0.03. The firm has a market cap of $3.50, a PE ratio of -0.06 and a beta of 0.32.
Rosetta Genomics Company Profile
Rosetta Genomics Ltd. is engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA) and protein biomarkers and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next Generation Sequencing (NGS) and Fluorescence In Situ Hybridization (FISH).
Receive News & Ratings for Rosetta Genomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rosetta Genomics and related companies with MarketBeat.com's FREE daily email newsletter.